Clefamide

Clefamide

SCHEMBL28086196

CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1.O=C(C(Cl)Cl)N(CCO)Cc1ccc(Oc2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.60
KMT2A Q03164 5/20 0.60
CYP3A4 P08684 2/20 0.60
HIF1A Q16665 1/20 0.60
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 4/20 0.42
MAPT P10636 4/20 0.42
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
F2 P00734 1/20 0.40
POLB P06746 1/20 0.39
NR3C1 P04150 1/20 0.37
KDM4E B2RXH2 2/20 0.36
HTT P42858 2/20 0.36
PKM P14618 1/20 0.36
MEN1 O00255 3/20 0.36
MC4R P32245 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clefamide SCHEMBL672628 0.82 LMNA (0.46) ALDH1A1KMT2ALMNAMAPTNPSR1
Diloxanide Furoate SCHEMBL23381 0.78 KMT2A (1.00) ALDH1A1KMT2ACYP3A4HIF1ALMNA
SCHEMBL11782643 0.77 LMNA (0.49) ALDH1A1KMT2ALMNAMAPTNPSR1
Diloxanide Furoate SCHEMBL4706808 0.77 KMT2A (0.97) ALDH1A1KMT2ACYP3A4HIF1ALMNA
SCHEMBL11778961 0.75 LMNA (0.51) ALDH1A1KMT2ALMNAMAPTNPSR1
SCHEMBL11780196 0.74 MC4R (0.53) ALDH1A1KMT2ALMNAMAPTNPSR1
SCHEMBL11780000 0.74 MC4R (0.53) ALDH1A1KMT2ALMNAMAPTNPSR1
SCHEMBL11779835 0.73 ALDH1A1 (0.51) ALDH1A1KMT2ALMNASMN1; SMN2NR3C1
Etofamide SCHEMBL1163863 0.72 KCNH2 (0.46) ALDH1A1KMT2ALMNAMAPTNPSR1
SCHEMBL11780552 0.70 LMNA (0.45) ALDH1A1KMT2ALMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed